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A method is provided for producing an arti?cial infection in 
a Culicidae (mosquito) species. The mosquitoes include spe 
cies Within the subfamilies Culicinae and Anophelinae, and 
the species include Aedes albopictus, Aedes aegypti and 
Aedespolynesiensis infected With a Wolbachia infection. The 
infection may be a strain of Wolbachia Which does not nor 
mally or naturally infect the selected mosquito species. The 
arti?cially infected Aedes mosquito can be introduced into a 
mosquito population to control the reproduction capability of 
the population by introducing an incompatible Wolbachia 
infection. The present method can be used as a novel means to 
limit mosquito-borne pathogens and thus control or prevent 
mosquito-borne diseases such as dengue, lymphatic ?lariasis, 
etc. 
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TRANSFECTED MOSQUITO VECTORS 
FIELD OF THE INVENTION 
The present invention relates to transfected mosquito vec 
tors and in particular Diptera: Culicidae (mosquito) vectors 
transfected With Wolbachia. 
BACKGROUND OF THE INVENTION 
Malaria, dengue and dengue haemorrhagic fever, WNV 
and other encephalites, human African trypanosomiasis 
(HAT), human ?lariasis, dog heartWorm and other pathogens 
important to animals are on the increase. Although vector 
control methods are available to interrupt transmission of 
these diseases, their effectiveness has been limited by logistic 
problems, development of resistance to insecticides, regula 
tory restrictions related to environmental concerns and high 
cost. Novel, sustainable approaches to control are urgently 
needed. 
Recent molecular advances in the understanding of vector 
genetics and vector-parasite/virus relationships have pro 
vided novel tools for the study of disease transmission. 
Among these are germ-line transformation of mosquitoes, 
detailed genetic and physical maps, molecular genetic mark 
ers for the identi?cation of cryptic species, detection of patho 
gens in vectors, gene ?oW studies, detection of insecticide 
resistance, and the complete genome of Anopheles gambiae 
as Well as collections of expressed sequence tags (ESTs) from 
a variety of disease vectors. HoWever, much Work remains to 
be done to identify, at the molecular level, the role of insect 
vectors in disease transmission, and the mechanisms for inter 
fering With vector competence. 
Insect vectors of disease constitute a major threat to human 
and animal health. Malaria, the most prevalent of the mos 
quito-bom diseases, af?icts 300-400 million people annually, 
of Which about 1% die from the disease. Malaria and other 
vector-borne diseases are increasing in the World today for a 
variety of reasons, including vector resistance to pesticides, 
parasite resistance to drugs, more movement by people, cli 
matic changes, etc. Warm areas of the United States, such as 
AriZona, With its proximity to the reservoirs of disease in 
Central America, are especially vulnerable to spread of vec 
tor-borne diseases. Attempts to lessen the impact of malaria 
and the other insect-born diseases require extensive knoWl 
edge of the vector insect, of the causative agent, and of the 
interaction betWeen vector and parasite or vector and virus. 
The primary indirect effect of medical and veterinary 
insects is disease transmission. Indeed, disease transmission 
is more important than any other effect produced by medical 
and veterinary pests. Underlying the relationship of arthro 
pods to disease requires consideration of many concepts and 
much terminology. 
Organisms that produce disease are called pathogens and 
disease itself is a stress condition produced by the effects of a 
pathogen on a susceptible host. Arthropods capable of trans 
mitting pathogens are called vectors. Some diseases may 
depend on only a single host and a vector; hoWever, other 
diseases may include multiple host species, and even multiple 
vectors. In many of these instances, an organism that main 
tains the infective agent (the pathogen source) When active 
transmission does not occur is termed a reservoir. For 
example, the reservoir for malaria is human populations, With 
transmission occurring When a mosquito feeds on an infected 
individual and later feeds on an uninfected individual. 
Fundamentally, disease is a manifestation of interactions 
betWeen host and pathogen. An array of environmental and 
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physiological factors may in?uence these interactions. Many 
aspects of insect behavior and life history are important in 
disease transmission, especially those relating to relation 
ships betWeen vectors and hosts. Generally, the closer the 
association betWeen vector and host, the greater the suitabil 
ity of the vector to transmit the disease. 
Aedes aegypli, Aedes albopiclus, and Aedes polynesiensis 
are medically important vectors of pathogens including den 
gue, yelloW fever, ?lariasis, dog heartWorm, West Nile and 
other encephalites. The transfected strains that have been 
generated may be used to suppress, eliminate or replace natu 
rally occurring vector populations. 
Wolbachia is a genus of obligate, intracellular, maternally 
inherited bacteria that occur in many insect species. Cytoplas 
mic incompatibility (CI) is one of several reproductive 
manipulations caused by Wolbachia. CI occurs in matings 
betWeen individuals that differ in their Wolbachia infection 
type and results in early embryonic death. The CI mechanism 
is unknown as disclosed by Charlat, S., Calmet, C., Mercot, 
H., 2001 “On the mod resc model and the evolution of Wol 
bachia compatibility types”, Genetics 159, 1415-1422, (here 
inafter Charlat 2001); Poinsot et al. “On the mechanism of 
Wolbachia-induced cytoplasmic incompatibility: confront 
ing the models With the facts”, Bioessays 25, 259-265, 2003; 
and Dobson, S. L., Rattanadechekul, W., Marsland, E. 1., 
“Fitness advantage and cytoplasmic incompatibility in Wol 
bachia single and super-infectedAedes albopiclus”, Heredity 
93, 135-142, 2004 (hereinafter Dobson 2004). Wolbachia in 
the male acts to ‘modify’ the sperm, such that karyogamy 
failure occurs folloWing fertilization, resulting in embryo 
death. If the female (and resulting fertilized egg) have the 
same Wolbachia type as her mate, Wolbachia acts to ‘rescue’ 
the modi?cation, resulting in normal embryo development. 
Thus, matings betWeen uninfected females and infected 
males are incompatible, but the reciprocal cross is compatible 
(unidirectional CI). Unidirectional CI provides Wolbachia 
infected females With a reproductive advantage relative to 
uninfected females, promoting the spread of maternally 
inherited Wolbachia into uninfected host populations. The 
ability to spread into host populations has led to the proposed 
use of Wolbachia in population replacement strategies. Spe 
ci?cally, a desired transgene that is linked to Wolbachia could 
be ‘seeded’ into a mosquito disease vector population. The 
Wolbachia infection Would then serve as a vehicle, driving the 
linked transgene into the targeted population. Additionally, 
the introduced Wolbachia infection may directly have a 
desired impact on the targeted insect population (i.e., genetic 
modi?cation of Wolbachia strain not required). Bidirectional 
CI can occur When tWo or more Wolbachia types infect the 
same host population. An example is provided by the parasi 
toid Wasp Nasonia vilripennis. Crosses betWeen N. vilripen 
nis strains that are infected With divergent Wolbachia types (A 
type or B type) result in incompatibility in both cross direc 
tions. Theory predicts that bidirectionally incompatible Wol 
bachia types cannot persist Within a panmictic host popula 
tion as taught by Rousset, F., Raymond, M., Kjellberg, F., 
1991, “Cytoplasmic incompatibilities in the mosquito culex 
pipiens: hoW to explain a cytotype polymorphism?”, J. Evol. 
Biol. 4, 69-81, (hereinafter Rousset 1991); and Dobson, S. L, 
Fox, C. W., Jiggins F. M., 2002, “The effect of Wolbachia 
induced cytoplasmic incompatibility on host population siZe 
in natural and manipulated systems”, Proc. R. Soc. London B 
Biol. Sci. 269, 437-445, (hereinafter Dobson 2002), both 
incorporated herein by reference. Bidirectional CI causes a 
‘battle’ betWeen the Wolbachia types, resulting in the elimi 
nation of infections until only one Wolbachia type predomi 
nates. The host population is a victim during this battle, as 
US 7,868,222 B1 
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bidirectional incompatibility steriliZes many matings. The 
CI-induced suppression of the host population is transient 
however, lasting only until one Wolbachia infection type 
dominates the host population. Therefore, knoWn examples 
of bidirectional CI have been either arti?cially generated or 
isolated from allopatric populations. 
Vector population suppression and elimination strategies 
are based upon arti?cially prolonging the bidirectional CI 
battle as taught by Dobson 2002. In a prior ?eld test of the 
strategy, releases of bidirectionally incompatible males suc 
cessfully eliminated a Culex mosquito vector population 
from a village in Burma (Myanmar) as provided in Laven, H. 
1967. “Eradication of Culex pipiens fatigans through cyto 
plasmic incompatibility”. Nature 216: 383 -3 84. HoWever, the 
availability of naturally occurring bidirectionally incompat 
ible strains that permitted the Culex strategy remains unique 
among mosquitoes. Therefore, the use of the suppression/ 
elimination strategy in additional mosquito vector popula 
tions requires the ability to arti?cially generate incompatible 
strains. Similarly, population replacement strategies also 
require an ability to generate novel infections. Although the 
arti?cial transfer of Wolbachia (transfection) has been suc 
cessfully accomplished in other insect systems as taught by 
Boyle et al., “Interspeci?c and intraspeci?c horiZontal trans 
fer of Wolbachia in Drosophilia” Science 260, 1796-1799, 
1993; Sasaki et al., “Interspeci?c transfer of Wolbachia 
betWeen tWo lepidopteran insects expressing cytoplasmic 
incompatibility; a Wolbachia variant naturally infecting 
Cadra caulella causes male killing in Epheslia kuehniella”, 
Genetics 162, 1313-1319, 2002; Hartmann et al., “Trans 
species transfer of Wolbachia: micro-injection of Wolbachia 
from Litomosoides sigmodontis into Acanthocheilonema 
viteae”, Parasitology 126, 503-511, 2003; and Kang et al., 
“Superinfection of Laodelphax slrialellus With Wolbachia 
from Drosophila simulans”, Heredity 90, 71-76 2003, prior 
efforts to generate novel infections in mosquitoes have not 
proven successful as shoWn by Sinkins, S. P., O’Neill, S. L., 
“Wolbachia as a vehicle to modify insect populations.”, In: 
James, A.M.H.A.A. (Ed.), Insect Transgenesis: Methods and 
Applications, CRC Press, Boca Raton, Fla., pp. 271-287, 
2000, all incorporated herein by reference. 
Aedes albopiclus (Asian tiger mosquito) is a medically 
important disease vector of multiple arboviruses and ?laria. 
This mosquito is also an important invasive species, fre 
quently spread by human transport. Since its introduction to 
the United States, Ae. albopiclus has spread to become a 
leading biting nuisance. Ae. albopiclus individuals are natu 
rally co-infected With tWo Wolbachia types (WAlbA and 
WAlbB). This type of co-infection is knoWn as ‘superinfec 
tion’ and is commonly observed in insects. Superinfection 
results in additive unidirectional CI: superinfected females 
express both the A and B rescue and are compatible With all 
males in the population; superinfected males express both the 
A and B modi?cation and are compatible only With superin 
fected females. 
Although a majority of Ae. albopiclus populations are 
superinfected, laboratory colonies of single-infected 
(WAlbA) strains have been established from the islands of 
Koh Samui and Mauritius. Crosses demonstrate that the 
superinfection is unidirectionally incompatible With the 
WAlbA infection. 
Crosses of WAlbA-infected females and super-infected 
males are incompatible, resulting in high embryo mortality. 
The males in the latter cross differ only by the WAlbB infec 
tion present in males. 
Aedes aegypli (yelloW fever mosquito) is the principle vec 
tor of dengue viruses throughout the tropical World. Without 
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a registered vaccine or other prophylactic measures, efforts to 
reduce cases of dengue fever and dengue hemorrhagic fever 
are limited to vector control. Unfortunately, traditional mos 
quito control measures are not succeeding. With an estimated 
100 million human cases of dengue fever every year, substan 
tial effect is being devoted to the development of neW strate 
gies to complement existing vector control methods. 
A gene drive vehicle is an important component of vector 
population replacement strategies, providing a mechanism 
for the autonomous spread of desired transgenes into the 
targeted population. Compared With strategies that rely on 
inundative releases and Mendelian inheritance, genedrive 
strategies Would require relatively small “seedings” of trans 
genic individuals into a ?eld population. Perhaps more 
important than increased cost e?icacy, gene drive strategies 
can facilitate population replacement With transgenic indi 
viduals that have a loWer ?tness relative to the natural popu 
lation. 
As previously noted, Cytoplasmic incompatibility (CI), 
induced by naturally occurring intracellular Wolbachia bac 
teria, has attracted scienti?c attention as a potential vehicle 
for gene drive. Although CI and other forms of reproductive 
parasitism have made Wolbachia an evolutionary success, 
With an estimate that infections occur in ~20% of insect 
species, Wolbachia infections do not naturally occur in A. 
aegypli, raising the questions of Whether A. aegypli can sup 
port a Wolbachia infection. Key parameters in Wolbachia 
infection dynamics include the intensity of CI (number of 
hatching eggs resulting from an incompatible cross), the 
maternal inheritance rates (number of uninfected progeny 
produced by an infected female) and mosquito ?tness costs 
associated With the infection. These parameters also deter 
mine the infection frequency after a population replacement 
event, an important consideration because of the goal of 
population replacement is for the entire mosquito population 
to carry the desired genotype. The parameters also determine 
the rate at Which the infection Will invade the targeted popu 
lation, an important consideration since the strategy should 
take place Within a “human, not evolutionary, time frame.” 
(N. Besansky, U. Notre Dame). 
SUMMARY OF THE INVENTION 
The present invention is directed to a novel approach for 
arti?cially infecting Culicidae (mosquito) species including 
the subfamilies Culicinae and Anophelinae With one or more 
Wolbachia strains. For example, Culicidae species include 
Aedes albopiclus, Aedes aegypli, and Aedes polynesiensis. 
The Wolbachia strain may include both strains Which natu 
rally infect the aforementioned mosquito species as Well as 
strains Which do not naturally infect various mosquito spe 
cies. The Wolbachia infection to be microinjected may be 
derived in vivo (e.g., from embryonic, immature or adult 
insect tissues) or may be propagated in vitro (e.g., in a tissue 
culture) prior to injection. 
The present novel method provides for a means of gener 
ating speci?cally infected mosquito species as desired. The 
then generated infected mosquitoes can be employed to con 
trol a mosquito population by introducing a speci?c species 
infected With a speci?c Wolbachia infection into a population 
of mosquitoes to effect vector suppression, elimination, or 
replacement and to control the reproduction capability of the 
population. 
The present invention, in one form thereof, relates to an 
arti?cial bacterial infected insect species comprising an 
Aedes mosquito species selected from the group consisting of 
Aedes albopiclus, Aedes aegypli and Aedes polynesiensis 
US 7,868,222 B1 
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infected With one or more Wolbachia species Which does not 
naturally infect the selected Aedes mosquito species. 
The present invention, in another form thereof, relates to a 
bacteria infected insect species, selected from the group con 
sisting of Aedes aegypli and Aedes polynesiensis, infected 
With a Wolbachia species of bacteria. 
The present invention, in another form thereof, relates to a 
method of infectingAedes mosquito species With a bacterium 
comprising injecting an Aedes mosquito With either 1) cyto 
plasm from a donor species infected With Wolbachia or 2) cell 
culture comprising the Wolbachia, using microinjection. The 
Aedes mosquito species includes an Aedes mosquito species 
selected from the group comprising of Aedes albopiclus, 
Aedes aegypli and Aedes polynesiensis. 
The present invention, in another form thereof, relates to a 
method of mosquito population control comprising infecting 
an Aedes mosquito species With a Wolbachia infection by 
injecting an embryo from an Aedes mosquito With 1) cyto 
plasm from a donor species infected With Wolbachia or 2) cell 
culture comprising the Wolbachia, using microinjection and 
introducing Aedes mosquito species infected With Wolbachia 
infection into a population of mosquitoes to effect vector 
replacement With Wolbachia or population suppression or 
population elimination based on a Wolbachia incompatibility. 
In one further embodiment, the injected embryos are alloWed 
to mature and reproduce to form an infected population Which 
is then introduced into the environment population of mos 
quitoes. 
The present invention, in another form, comprises an arti 
?cial bacteria infected mosquito species infected With one or 
more Wolbachia species Which does not naturally infect the 
Culicidae species. 
The present invention, in yet another form, comprises a 
method of infecting a mosquito species With a bacterium, in 
Which the method comprises inj ecting an embryo from the 
mosquito species With 1) cytoplasm from a donor species 
infected With Wolbachia or 2) cell culture comprising the 
Wolbachia, using microinjection. 
The present invention, in another form, comprises a 
method of infecting Aedes polynesiensis With a bacterium, in 
Which the method comprises using introgression to infect the 
Aedes polynesiensis With Wolbachia. In one further embodi 
ment, the Wolbachia is from Ae. riversi. 
The present invention, in yet another form, comprises a 
method of mosquito population control, in Which the method 
comprises infecting a mosquito species With a Wolbachia 
infection by injecting an embryo from the selected mosquito 
species With 1) cytoplasm from a donor species infected With 
Wolbachia or 2) cell culture comprising the Wolbachia, using 
microinjection; and introducing the mosquito species 
infected With a Wolbachia infection into a population of mos 
quitoes to effect vector replacement With the Wolbachia, or 
population suppression or population elimination based on 
Wolbachia incompatibility. 
The present invention, in yet another form, comprises a 
method of mosquito population control, Wherein the method 
comprises infecting a mosquito species With a Wolbachia 
infection using introgression to infect the mosquito With Wol 
bachia; and introducing the mosquito species infected With a 
Wolbachia infection into a population of mosquitoes to effect 
vector replacement With the Wolbachia, or population sup 
pression or population elimination based on Wolbachia 
incompatibility. 
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BRIEF DESCRIPTION OF THE DRAWINGS 
Further advantages and characteristics Will become evi 
dent from the folloWing description of preferred embodi 
ments according to this invention, presented for exemplifying 
and non-limiting purposes With reference to the attached 
draWings, in Which: 
FIG. 1 is a chart schematically shoWing a method of trans 
fecting mosquitoes With Wolbachia and using transfected 
mosquitoes to control mosquito populations in accordance 
With the present invention; 
FIG. 2 is a PCR gel shoWing a strain-speci?c ampli?cation 
of WAlbA and WAlbB Wolbachia type; 
FIG. 3 is a micrograph in Which panel (a) shoWs the dis 
tribution of Wolbachia inAe. albopiclus ovaries and panel (b) 
shoWs the distribution of Wolbachia in Ae. albopiclus 
oocytes; 
FIG. 4 (a)-FIG. 4 (c) are plots shoWing egg hatch rates 
Wherein FIG. 4 (a) is the egg hatch rate compatible G3 
crosses, FIG. 4 (b) is the hatch rate in incompatible G3 crosses 
and FIG. 4 (c) is the percent hatch rate in unintrogressed and 
introgressed WAlbB lines, Where egg hatch rate measurement 
Were either Weekly (FIGS. 4 (a), 4 (b)) or once per generation 
(FIG. 4 (0)); 
FIG. 5 is a micrograph of oocytes of uninfected Waco 
WAlbB-infected WBl stained anda Wolbachia-speci?c FISH 
probe; 
FIG. 6 (a) is a plot depicting Wolbachia infection fre 
quency and FIG. 6 (b) is a plot depicting egg hatch rates after 
a single release of WBl females into Waco populations, 
Whereby the plots display model predictions of Wolbachia 
infection dynamics assuming complete CI, 100% material 
transmission and 15% fecundity cost associated With Wolba 
chia infection; 
FIG. 7 is a micrograph shoWing Wolbachia distribution in 
oocytes of naturally superinfected (Hou) aposymbiotic (HTl) 
and WRi tranfected HTR strain; 
FIG. 8 is a PCR gel shoWing a diagnostic pattern of ampli 
?cation products resulting With Wolbachia speci?c PCR 
primers Where the depicted gel illustrates all of the ampli? 
cation products that result When each Ae. albopiclus strain is 
ampli?ed With all four primer sets; 
FIG. 9 is a graph depicting suppression of egg hatch in 
populations of naturally super-infectedAe. albopiclus (Hou) 
via release of transfected HTR males; and 
FIG. 10 is a schematic shoWing infection of Culicidae 
using introgression in accordance With the present invention. 
DETAILED DESCRIPTION 
The present method uses microbial pesticides in the form 
of Wolbachia for the suppression/elimination of mosquitoes 
and genetic strategies that reduce orblock pathogen transmis 
sion by mosquitoes as a means to control mosquito popula 
tions. These strategies include vector suppression and 
replacement based upon intracellular Wolbachia bacteria, 
Which occur naturally in many insect populations. One 
mechanism is cytoplasmic incompatibility (CI) through 
Which Wolbachia promotes infection spread by effectively 
sterilizing uninfected females. 
The present method employs Wolbachia as a vehicle to 
drive desired transgenes into vector populations (population 
replacement). The present method also provides for the sup 
pression/elimination of mosquitoes. Wolbachia-based popu 
lation suppression and population replacement strategies 
require an ability to generate arti?cial Wolbachia associations 
in mosquitoes. 
Referring noW to FIG. 1, method 10 is a method for trans 
fecting mosquitoes With one or more Wolbachia strains and 
using transfecting mosquitoes to effect vector suppressing 
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and/or vector replacement and to control mosquito popula 
tions in accordance With one form of the present invention. 
When used With regard to the present invention, the terms 
“transfected” and “transinfected” are synonymous With one 
another. At step 20, cytoplasm is WithdraWn from a donor 
infected With a Wolbachia infection. The donor may include 
a mosquito strain infected With Wolbachia. Alternatively, the 
donor can be a non-mosquito insect, Which has a Wolbachia 
infection such as a Drosophila. 
A recipient mosquito species including the subfamilies 
Culicinae and Anophelinae are then microinjected With the 
cytoplasm from the infected donor at step 30. Advanta 
geously, a suitable microinjector or syringe is used to extract 
the cytoplasm from the donor infected insect (step 30). Mos 
quito species of genus Aedes (also referred to by some as its 
alternate or synonymous name, Ochelerolalus, hereinafter 
referred to exclusively by its Aedes nomenclature) include 
Aedes albopiclus, Aedes aegypli, and Aedes polynesiensis. 
The strain of Wolbachia may include both Wolbachia Which 
naturally infects the selected mosquito species or may be a 
strain of Wolbachia Which does not infect the selected Aedes 
mosquito species naturally. For example, WAlbB, WMelPop 
and WRi can be introduced into Aedes albopiclus via micro 
injection. WAlbB can be introduced into anAedes aegypli via 
microinj ection. WCon can be introduced into Aedes polyne 
siensis via introgression. 
In an alternative to directly microinjecting the recipient 
mosquito With the cytoplasm from a donor species having a 
Wolbachia infection, Wolbachia can be groWn, in vitro, in cell 
culture media using culture techniques knoWn to one of ordi 
nary skill in the art as taught by: Dobson, S. L., E. J. Marsland, 
Z. Veneti, K. BOUITZIS, and S. L. O’Neill. 2002. Characteriza 
tion of Wolbachia host cell range via the in vitro establish 
ment of infections. Appl Environ Microbiol 68: 656-660. 
Subsequently, the in vitro groWn Wolbachia is microinjected 
into the recipient mosquito embryo. 
Steps 20 and 30 can be repeated to create superinfections, 
i.e. an mosquito infected With tWo Wolbachia strains and 
repeated a second time to produce a triple infection. For 
example, Aedes albopiclus can be injected With both WAlbA 
and WAlbB to cause a superinfection and also injected With 
WRi to cause a triple infection by repeating steps 20 and 30. 
Alternatively, the donor may have a superinfection so that 
injection the cytoplasm from the donor into the recipient 
results in a superinfection in the recipient mosquito. 
At step 40, the embryos are alloWed to mature and at step 
50, the selection and establishment of Wolbachia infected 
lines are generated. Wolbachia infected lines are established 
by screening females (G0) surviving the microinjection pro 
cess for Wolbachia infection using a PCR assay. Lines estab 
lished from females that are not infected are discarded. Lines 
established from females that are infected are continued by 
generating sublines and PCR assays as in the preceding gen 
eration. 
At step 60, expansion and characteriZation of appropriate 
lines is conducted. Lines that are stably infected With Wolba 
chia are expanded by continuing to rear all offspring gener 
ated by females. As one female can generate several hundred 
eggs, the line can be expanded to thousands of insects Within 
a feW generations. And, at step 70, the expanded and charac 
teriZed lines are reared in mass. 
If one Wishes to introduce the Wolbachia infection into a 
mosquito population (population replacement strategy), at 
step 80, infected female mosquitoes are released. Subse 
quently, at step 90, the selected females are released into the 
environment of a mosquito population to effect vector 
replacement. 
If one Wishes to affect a population suppression or popu 
lation elimination, at step 100, infected male mosquitoes are 
selected and then subsequently released or introduced into a 
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population of uninfected or differently infected mosquitoes in 
the environment at step 116. Infected males are alloWed to 
fertilize uninfected or differently Wolbachia infected female 
mosquito eggs thereby suppressing or eliminating the popu 
lation of Aedes mosquitoes in the selected population. 
Although method 10 uses microinjection to infect mos 
quito embryos, Which are alloWed to mature, before being 
released into a population to control, suppress or effect vector 
replacement, other prior techniques can be used to arti?cially 
infect a mosquito. For example, introgression using a tech 
nique such as the method schematically shoWn in FIG. 10, can 
be used rather than microinjection to introduce a desired 
Wolbachia infection. 
Prior crossing experiments demonstrated that egg hatch 
can be induced in interspeci?c crosses of Ae. polynesiensis 
and Ae. riversi by the removal of Wolbachia infection, sug 
gesting a strategy shoWn in FIG. 10 for the introgression of 
Wolbachia from Ae. riversi into Ae. polynesiensis in accor 
dance With Dean, J. L., and S. L. Dobson. 2004, “Character 
iZation of Wolbachia infections and interspeci?c crosses of 
Aedes (Stegomyia)p0lynesiensis andAe. (Stegomyia) riversi 
(Diptera: Culididae)”, J. Med. Entomol. 41: 894-900 (here 
inafter Dean and Dobson 2004), herein incorporated by ref 
erence. The foundation of the introgression strategy is based 
upon generating hybrids (named ‘CPl ’) from crosses of Wol 
bachia infected Ae. riversi females (AR) and APMT males. 
The APMT strain Was generated via antibiotic treatment of 
the naturally infected APM strain. Subsequently, crosses of 
CPl females WithAPMT males generated CP2 females, Which 
Were also crossed With APMT males. Repeating this cross 
pattern (intro gression) for multiple generations resulted in the 
CP strain that is predominantly Ae. polynesiensis genotype, 
but that is infected With the Wolbachia infection from Ae. 
riversi as shoWn in Dean and Dobson. 2004. 
It Will be apparent to one of ordinary skill in the art that the 
present method can be used to replace a population of mos 
quitoes by using the present method to infect female mosqui 
toes With one or more Wolbachia strains and introducing 
those infected With Wolbachia into a population. As the Wol 
bachia infection spreads into the ?eld population, the infec 
tion can serve as a vehicle to carry desired transgenes into the 
targeted population. For example, the introduced transgene 
may reduce the ability of the mosquito to transmit a human 
pathogen. [tWo recent references describing transgenic popu 
lation replacement strategies: Travanty E A, Adelman Z N, 
Franz A W, Keene K M, Beaty B J et al. (2004) Using RNA 
interference to develop dengue virus resistance in genetically 
modi?ed Aedes aegypli. Insect biochemistry and molecular 
biology 34(7): 607-613.; Moreira L A, Wang J, Collins F H, 
Jacobs Lorena M (2004) Fitness of anopheline mosquitoes 
expressing trans genes that inhibit Plasmodi um development. 
Genetics 166(3): 1337-1341 .] Alternatively, the Wolbachia 
infection may have a direct effect on the mosquito population, 
Which is desired for the reduction of vector populations or 
disease transmission. 
The present method aids in controlling the groWing burden 
of vector-borne disease by population suppression/elimina 
tion, in Which a natural vector population is reduced or elimi 
nated, thus reducing or eliminating the capacity of the popu 
lation to transmit disease. The present method also aids in 
controlling vector-borne disease by population replacement, 
in Which a natural vector population is replaced by a popula 
tion With a reduced capacity for disease transmission. An 
important component of such strategy is the drive system, 
Which serves to spread a desired genotype into the targeted 
?eld population. As previously noted, endosymbiotic Wolba 
chia bacteria are potential transgene drivers, but infections do 
not naturally occur in some important mosquito vectors, nota 
bly Aedes aegypli. HoWever, using the present method, stable 
infections of WAlbB Wolbachia can be established in A. 
US 7,868,222 B1 
9 
aegypli and cause a high rate of Cytoplasmic Incompatibility 
(CI), and consequently the elimination of egg hatch. Labora 
tory cage tests demonstrate the ability of wAlbB to spread 
into an A. aegypli population after seeding of an uninfected 
population with infected females, reaching infection ?xation 
within seven generations. 
The present invention will now be described with regard to 
the following examples in the form of experiments which in 
no way limit the scope of the present invention. 
Example 1 
Transfer of Wolbachia from a Naturally 
SuperinfectedAe. albopiclus strain 
This example demonstrates the use of embryonic microin 
jection to transfer Wolbachia from a naturally superinfected 
Ae. albopiclus strain into an arti?cially generated aposymbi 
otic strain. The results show that transfection efforts have 
generated an arti?cial Wolbachia infection type (wAlbB 
single infection) in Ae. albopiclus. Crossing experiments 
with the arti?cial infection show a new CI crossing type, 
providing the ?rst example of bidirectional incompatibility in 
Aedes mosquito strains. 
The Koh Samui strain of Ae. albopiclus (Koh; Thailand, 
pre-1970) is infected with the wAlbA Wolbachia type in 
accordance with Sinkins et al., “Wolbachia superinfections 
and the expression of cytoplasmic incompatibility”, Proc. R. 
Soc. London B Biol. Sci. 261, 325-330, 1995, (hereinafter 
Silkins 1995), herein incorporated by reference. The Houston 
strain is superinfected with both wAlbA and wAlbB Wolba 
chia types. HT1 and UjuT are uninfected strains that were 
arti?cially generated by tetracycline treatment in accordance 
with Otsuka and Takaoka, “Elimination of Wolbachiapipien 
Zis from Aedes albopiclus”, Med. Entomol. Zool. 48, 257 
260, 1997; and Dobson and Rattanadechakul, “Wolbachia 
induced cytoplasmic incompatibility in single- and superin 
fectedAedes albopiclus (Diptera: Culicidae)”, J. Med. Ento 
mol. 38, 382-387, 2001 (Dobson 2001), both herein incorpo 
rated by reference. Mosquitoes were maintained as 
previously described in accordance with Dobson et al., “A 
novel technique for removing Wolbachia infections from 
Aedes albopiclus” (Diptera: Culicidae), J. Med. Entomol. 38, 
844-849, 2001 (hereinafter Dobson et al., 2001) herein incor 
porated by reference. 
Microinjection 
Embryo injection was based upon techniques successfully 
used for mosquito transgenesis as taught by Morris, “Micro 
injection of mosquito embryos”, In: Crampton, J. M., Beard, 
C. B., Loius, C. (Eds.), Molecular Biology of Insect Disease 
Vectors: A Methods Manual, Chapman & Hall, 423-429, 
1997 (hereinafter Morris); Coates et al., “Mariner transposi 
tion and transformation of the yellow fever mosquito, Aedes 
aegypzi”, Proc. Natl. Acad. Sci. USA 95, 3748-3751, 1998 
both herein incorporated by reference. Injection needles 
(Quartz with ?lament, O.D.: 1.0 mm, ID: 0.70 mm) were 
pulled with a P2000 micropipette puller (Sutter Instrument 
Co.; Novato, Calif.). Approximately ten blood-fed females 
(Hou or HT1) were held in Drosophila vials (Fisher Scien 
ti?c) containing a wet ?lter paper funnel. HT1 embryos to be 
injected (recipient embryos) were collected after allowing 
females to oviposit for 290 min. Following a brief desicca 
tion, gray embryos were aligned on double sided tape (Scotch 
665; St. Paul, Minn.) and covered with halocarbon 700 oil 
(Sigma-Aldrich Co.). Donor Hou embryos were treated simi 
larly but not desiccated. Cytoplasm was withdrawn from 
donor Hou embryos and injected into the posterior of recipi 
ent HT1 embryos using an IM300 microinjector (Narishige 
Scienti?c; Tokyo, Japan) as previously described by Morris. 
After injection, the embryos were incubated at 80% relative 
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humidity and 27° C. for approximately 40 min. Embryos 
were then removed from oil and transferred to wet ?lter paper. 
Embryos were allowed to develop for 5 days on wet egg 
paper. Subsequently, the eggs were hatched (GO) and reared 
using standard maintenance conditions as above. 
Crosses of Transfected Lines 
To ensure a compatible mating, GO females were isolated as 
virgins and mated with HT1 males. Following oviposition, GO 
females were assayed for Wolbachia infection using PCR. GO 
males were also PCR assayed for Wolbachia infection. GO 
females testing negative for Wolbachia infection were dis 
carded along with their progeny. Infected Gl females were sib 
mated, blood fed, isolated and allowed to oviposit. Following 
oviposition, Gl females were PCR assayed for Wolbachia 
infection. Gl females testing negative for Wolbachia infection 
were discarded along with their progeny. An introgressed line 
was generated by crossing wAlbB-infected females with 
UjuT males as previously described in Dobson et al., “Fitness 
advantage and cytoplasmic incompatibility in Wolbachia 
single- and superinfected Aedes albopiclus”, Heredity 93, 
135-142, 2004, (hereinafter Dobson 2004). To determine CI 
levels, ?ve virgin females were mated with ?ve virgin males 
at G3. Mated females were blood fed weekly using mice. 
Oviposition sites were available constantly to females, and 
oviposition paper was changed weekly. Hatch rates were 
scored 3 days after eggs were immersed into water. Amaj ority 
of Ae. albopiclus eggs hatch within a few hours of being 
submerged in deoxygenated water. Thus, delaying observa 
tions beyond 3 days would not affect estimates of egg hatch. 
PCR Ampli?cation 
Ovaries or testis of adults were dissected and homogenized 
in 100 ul STE with 0.4 mg/ml proteinase K to extract DNAs 
previously described in accordance with O’Neill et al., 
“rRNA phylogenetic analysis of the bacterial endosymbionts 
associated with cytoplasmic incompatibility in insects”, Proc. 
Natl. Acad. Sci. USA 89, 2699-2702, 1992 (hereinafter 
O’Neill 1992), incorporated herein by reference. General 
Wolbachia primers (81F-681R) and primers speci?c for the 
wAlbA (328F-691 R) and wAlbB (183F-691R) infections 
were used as previously described in Zhou et al., “Phylogeny 
and PCR-based classi?cation of Wolbachia strains using wsp 
gene sequences”, Proc. R. Soc. London B Biol. Sci. 265, 
509-515, 1998 (hereinafter Zhou 1998), incorporated herein 
by reference. 
Fluorescence In Situ Hybridization (FISH) 
Dissected ovaries and oocytes were ?xed for 15 min in 
freshly prepared 4% formaldehyde in PBS and then washed in 
PBS with 0.1% Tween 20. Hybridization was conducted fol 
lowing the manufacturers instruction (GeneDetect, Braden 
ton, Fla.) with buffer containing 200 ng probes at 37° C. 
overnight. Two FITC 50-end labeled 16s rDNA Wolbachia 
probes (synthesized by Sigma-Genosys Ltd., Haverhill, UK) 
were used with the sequence as following: [5'-ACCAGATA 
GACGCCTTCGGCC-3'] (SEQ ID NO: 1) and [5'-CTTCT 
GTGAGTACCGTCATTATC-3'] (SEQ ID NO: 2). Following 
hybridization, samples were washed at 45° C. and mounted 
on a glass slide with Vecta shield mounting media (Vector 
Laboratories; Burlingame, Calif.). Samples were viewed with 
Olympus IX70 ?uorescence microscope and photographed 
using Magna?re software (Optronics; Goleta, Calif.). 
Results of the Experiment 
Cytoplasm from superinfected Ae. albopiclus embryos 
(Hou) were microinjected into uninfected embryos (HT1). In 
one experiment, ten of 77 embryos (GO) survived microinj ec 
tion (12% hatch rate). Two of the resulting adults were 
female. Since males are a dead end host for Wolbachia infec 
tion, males were not used to establish lines. Instead, the eight 
adult males were sacri?ced for PCR Wolbachia detection 
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assays as shown in FIG. 2. Three males Were PCR positive for 
both the WAlbA and WAlbB Wolbachia infection; tWo males 
Were positive for only the WAlbB infection; Wolbachia Was 
not detected in the remaining three males. 
PCR tests of infected GO females shoWed one GO female to 
be positive for both the WAlbA and WAlbB infection. Wolba 
chia Was not detected in the second GO female. TWenty-one 
Gl isofemale lines Were established from the infected GO 
female. Gl PCR assays demonstrated 11 females to be posi 
tive for the WAlbB infection only. One G 1 female Was positive 
for the WAlbA infection only. Wolbachia Was not detected in 
the remaining nine Gl females. 
Three WAlbB-infected isofemale lines Were established. 
Eggs from the WAlbA-infected Gl female failed to hatch, and 
thus this line Was lost. To determine the stability of Wolbachia 
infection in the WAlbB-transfected lines, PCR Was repeated 
in subsequent generations. Consistent PCR detection of the 
infection continued through the generation immediately prior 
to submission of this article (GO). 
To characteriZe the distribution of Wolbachia in the trans 
fected line, ovaries Were dissected from G6 females and 
examined. Hou and WAlbB oocytes displayed a similar pat 
tern of Wolbachia staining at both embryonic poles, Which 
Was absent from uninfected oocytes as shoWn in FIG. 3. In 
FIG. 3, HT1 is an aposymbiotic (uninfected) strain; WAlbB is 
the transfected strain; and Hou is the naturally superinfected 
strain. A reduced level of Wolbachia Was observed in ovaries 
of WAlbB females compared to ovaries of superinfected Hou 
females. 
Crosses to characteriZe the Cl pattern of the transfected 
WAlbB strain resulted in a loW egg hatch rate in crosses of 
WAlbB males With either uninfected or WAlbA-infected 
females as summariZed in Table 1. Crosses of the WAlbB 
males With superinfected females are compatible. Crosses of 
the WAlbB females With uninfected or WAlbB-infected males 
Were compatible, although relatively loW egg hatch rate 
(38.0%) Was observed in the latter crosses as summariZed in 
Table 1 beloW. Cl persists over the lifetime of WAlbB females. 
TABLE 1 
Crosses ofthe transfected WAlbB line (G1) 
Number Ovi 
Expected Percent egg of egg position 
CI type Cross” hatchl7 ovipositionl7 number 
Bidirectional WAlbB x Koh 3.6 r 3.8 155 r 55 13 
CI Koh x WAlbB 2.4744 162 z 64 15 
Unin- HT1 x WAlbB 0.0 r 0.0 170 z 45 14 
directional CI WAlbB x Hou 3.0 r 2.1 150 r 52 6 
Compatible Hou x WAlbB 73.8 r 12.1 192 r 60 15 
WAlbB x WAlbB 38.0 r 21.3 139 z 48 6 
HT1>< HT1 90.9 r 2.7 166 :139 3 
Koh x Koh 88.0 r 2.8 177 z 85 4 
HouxHou 82.5 12.2 158 :57 4 
“Female X male; HT1 is an aposymbiotic (uninfected) strain; WAlbB is the transfected strain; 
Koh is a WAlbA-infected strain; and Hon is the naturally superinfected strain 
Average i standard deviation 
Egg hatch Was observed to remain consistent in egg 
batches collected from the same females over a 4-week period 
as shoWn in FIGS. 4 (a) and 4 (b). The CI level Was re 
examined at G7, resulting in similar results as G3. ShoWn in 
FIGS. 4 (a) and 4 (b), crosses are female><male; HT1 is an 
aposymbiotic (uninfected) strain; WAlbB is the transfected 
strain; Koh is a WAlbA infected strain; and Hou is the natu 
rally superinfected strain. Greater than 86% hatch resulted in 
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crosses of WAlbB males With superinfected Hou females. No 
egg hatch Was observed in crosses of WAlbB males and unin 
fected HT1 females. 
To reduce potential inbreeding effects, one WAlbB line Was 
introgressed With UjuT for three generations. As shoWn in 
FIG. 4 (c), the hatch rate in the introgressed strain increased to 
greater than 93%. The hatch rate observed in the un-intro 
gressed WAlbB line also increased (72.8% in G7; FIG. 4 (c)). 
lntrogression did not affect Cl. No egg hatch Was observed in 
crosses of introgressed WAlbB males and uninfected HT1 
females. Maternal inheritance rate Was examined in the 
WAlbB line by screening 20 G6 females using the PCR assay. 
Wolbachia infection Was observed in all of the tested females. 
To examine for paternal transmission, rare progeny from 
incompatible crosses Were reared to adult and then PCR 
assayed for infection type. Superinfection Was not detected in 
the three progeny resulting from WAlbB><WAlbA and tWo 
progeny from WAlbA><WAlbB (female><male). The infection 
type in each of the progeny Was consistent With expectations 
for maternal inheritance only (i.e., progeny infection type Was 
the same as the maternal type). 
Wolbachia in Ae. albopiclus is knoWn to represent a true 
superinfection (i.e., co-infection With tWo Wolbachia types) 
and not multiple copies of diagnostic genetic loci in a single 
Wolbachia type, based upon observations of the WAlbA 
single infection in mosquito lines and the WAlbB single infec 
tion in vitro. HoWever, the WAlbB single infection has not 
been ob served naturally. Surveys shoW that >99.4% of natural 
Ae. albopiclus populations are superinfected. Furthermore, 
prior efforts to segregate the WAlbA and WAlbB infections 
using antibiotics Were unsuccessful. 
Based upon the genetic divergence of the WAlbA and 
WAlbB infections and prior crossing experiments, bidirec 
tional incompatibility has been predicted for crosses betWeen 
individuals single-infected With WAlbA and WAlbB. Here, 
crosses of the transfected WAlbB line Were used to directly 
test predictions. Consistent With expectations for differing 
modi?cation and rescue mechanisms, less than 4% egg hatch 
rate resulted in crosses betWeen WAlbB males With either 
WAlbA or uninfected females as shoWn in Table 1. Crossing 
results demonstrate that the WAlbB infection is capable of 
inducing and rescuing the Cl modi?cation independent of the 
WAlbA infection. Crosses of WAlbB females With either 
WAlbA or superinfected males demonstrate that the WAlbB 
infection is unable to rescue the WAlbA modi?cation. 
Although prior characteriZation of Wolbachia infections in 
other insects shoWs that Cl levels can be affected by host age, 
the WAlbB infection in females is able to rescue modi?ed 
sperm until female death as shoWn in FIGS. 4 (a)-4 (0). 
Despite the observation that ovaries from the WAlbB line 
appeared to have loWer infection levels relative to Hou ovaries 
(FIG. 3), the WAlbB infection Was observed to be stably 
maintained in the transfected lines. PCR assays at G6 suggest 
maternal inheritance in excess of 95%, consistent With prior 
characterization of naturally infected lines. Wolbachia spe 
ci?c staining shoWed a similar infection level and Wolbachia 
distribution in WAlbB and Hou oocytes (FIG. 3). Paternal 
transmission of Wolbachia infection provides a potential 
route for the evolution of superinfections. With paternal and 
maternal transmission, survivors of crosses betWeen mates 
With different Wolbachia types Would result in superinfected 
progeny. To examine for paternal transmission, the rare off 
spring from incompatible crosses betWeen WAlbA and 
WAlbB strains Were PCR tested. In each case, the Wolbachia 
infection Was identical to the maternal infection type. 
LoW hatch rate (38.0%) Was observed in compatible 
crosses of WAlbB individuals. Hypotheses to explain this 
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observation include inbreeding effects associated With the 
establishment of isofemale lines (i.e., increased homoZygos 
ity of deleterious loci) and high mortality associated With the 
arti?cially generated single WAlbB infection type. The 
observed increase in egg hatch With introgression (FIG. 4 (c)) 
is consistent With predictions for an inbreeding effect. An 
increase in egg hatch Was also observed in subsequent gen 
erations of a non-introgressed WAlbB line, reaching a plateau 
at approximately 70% (FIG. 4 (0)). Thus, the WAlbB single 
infection does not appear to be associated With increased 
mortality. 
Although superinfection Was detected in GO individuals 
surviving microinjection, only single infections Were 
observed in G1. It is useful to note that subsequent to G1, 
maternal transmission loss Was not observed. 
The present method demonstrates a technique for Wolba 
chia transfection in Ae. albopiclus. An ability to generate 
arti?cial Wolbachia infections and neW CI crossing types 
represents an important advance toWard implementation of 
proposed Wolbachia-based strategies for suppression and 
replacement of medically important mosquito vector popula 
tions. Thus the experiments described here demonstrate a 
successful transfection protocol. 
For suppression strategies, injection of aposymbiotic Ae. 
albopiclus can be used to generate strains that are bidirection 
ally incompatible With the superinfected ?eld population. 
Injection of superinfectedAe. albopiclus can be used to gen 
erate a triple-infected Ae. albopiclus strain that is unidirec 
tionally incompatible With superinfected ?eld population. 
Example 2 
Transfecting A. aegypli by Microinj ection With 
WAlbB Wolbachia Infection 
A. aegypli Were infected by embryonic microinj ection With 
the WAlbB Wolbachia infection from A. albopiclus in accor 
dance With Xi and Dobson 2005. In brief, cytoplasm from A. 
albopiclus eggs (Hou strain superinfected With WAlbA and 
WAlbB) Was injected into A. aegypli eggs (Waco strain). 
Wolbachia Were detected by polymerase chain reaction 
(PCR) as previously described in Dobson, et al., Genetics 
160, 1087 (2002) (hereinafter Dobson 2002) and hereinafter 
incorporated by reference, in each of the ?ve females (GO) 
that survived from injection to adult. Only three females 
successfully produced progeny (G1). PCR tests of G1 indi 
viduals demonstrated the offspring of one female to be unin 
fected. The lines established from the remaining tWo females 
Were only infected With the WAlbB, and one line (designated 
WB1) Was selected for additional tests. In previous Work on 
A. albopiclus, WAlbB infections Were obtained and not 
WAlbA in accordance With Xi and Dobson 2005. This may 
re?ect the loWer infection rate of WAlbA relative to WAlbB. 
PCR assays of WB1 individuals in subsequent generations 
(éGlz) consistently identi?ed Wolbachia infection. As a spe 
ci?c test of the maternal inheritance rate, progeny Were col 
lected from isolated WB1 females (G12). After PCR con?r 
mation of Wolbachia infection in 10 G1 2 females, the progeny 
(10 daughters and 10 sons for each Gl2 female) Were assayed 
With PCR. All of the G13 progeny (n:200) Were infected by 
Wolbachia (95% binomial con?dence interval betWeen 
0.9851 and 1.0). Fluorescence in situ hybridization (FISH) 
con?rms high Wolbachia infection rates in WB1 oocytes 
(FIG. 5). The infection appears highest in the anterior, poste 
rior, and cortical regions of oocytes, similar to the pattern 
observed in naturally infected A. albopiclus. 
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Crosses Were conducted to determine Whether CI occurs as 
a result of the Wolbachia infection in the WB1 strain. The 
design of the cross experiment Was as previously described in 
Dobson 2002. As shoWn in Table 2, the pattern of egg hatch 
resulting from crosses is consistent With strong CI, similar to 
that observed in A. albopiclus, from Which the WAlbB infec 
tion Was derived. No egg hatch resulted from >3800 eggs 
examined from crosses of uninfected Waco females and 
infected WB1 males. 
TABLE 2* 
Male Waco Male WBl 
Female Waco 92.5 r 3.7% 0.0 100% 
(n = 9) (n = 15) 
Female WBl 69.1 r 11.7% 50.6 r 12.9% 
(n = 9) (n = 15) 
*CI pattern resulting from crosses ofthe naturally uninfected Waco and the WAlb-trans 
fected WBl A. aegypti strains. Percent egg hatch i standard deviation and number of cross 
replicates are shown for each ofthe four cross types. Crosses Were conducted as described 
in Xi and Dobson (2005). 
Among the compatible crosses, egg hatches resulting from 
WB1 crosses [51% and 69% (Table 2)] Were signi?cantly 
loWer [Kruskal-Wallis, df (degrees of freedom):1, P G 0.01] 
than the egg hatch observed in compatible crosses of Waco 
individuals (92%). Because the progeny of the WB1 GO 
female Were sibling-mated during production of the WB1 
isofemale line, the loW egg hatch may re?ect an inbreeding 
effect. Therefore, virgin WB1 females (G3) Were mated With 
uninfected Waco males. After the repeat of this introgression 
for six generations, the egg hatch increased to an average of 
89% (G9). 
Strong CI and high maternal transmission rates suggest 
that WAlbB infection Will invade an uninfected population. 
To test this prediction, WB1 females Were released at differ 
ent ratios into replicate Waco laboratory populations (FIG. 6 
(11)). The population cage experimental design Was as previ 
ously described in Dobson (2002). In the 20% initial release 
cage, the WAlbB infection frequency Was observed to 
increase to 100% infection frequency Within seven genera 
tions . Additional sampling in the eighth and ninth generations 
demonstrated that the infection frequency remained ?xed at 
100% (FIG. 6 (11)). Consistent With model predictions, a 
transient drop in egg hatch Was observed during the cytotype 
replacement (circa generation four) (FIG. 6 (11)). The latter is 
expected oWing to the frequent occurrence of CI crosses; 
hoWever, once the infection becomes ?xed Within the popu 
lation, CI crosses no longer occur, and the egg hatch rates 
recover. 
In cages established With an initial infection frequency of 
210%, the infection Was detected for up to four generations 
before its disappearance from the population (FIG. 6 (11)). 
Infection could not be detected in populations in cages ini 
tially infected at a rate of 2% release of WB1 females. Hence, 
the loss of Wolbachia infection from a population is predicted 
if the initial infection frequency is beloW a required threshold 
determined by CI level, ?delity of maternal transmission, and 
?tness costs associated With Wolbachia infection. Complete 
CI and no evidence of maternal transmission failure Were 
observed in this study. If no ?tness costs Were associated With 
the infection, one Would predict Wolbachia invasion in all 
cages in Which WB1 females Were released. HoWever, a 
threshold infection frequency of ~20% Was estimated Which 
provides evidence of there is a substantial ?tness cost asso 
ciated With WAlbB infection in A. aegypli. By using a previ 
ously developed model, an approximate 15% fecundity cost 
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Was estimated to be associated With the WAlbB infection on 
the basis of the observed population replacement events (FIG. 
6 (11)). 
An analysis of fecundity costs associated With the WAlbB 
infection neither revealed any differences in egg number 
(P>0.3, t test) in comparisons of WBl females (57.81176 
eggs per female, n:1 2) With Waco females (52.4185 eggs per 
female, n:14) nor revealed any differences in egg hatch rate 
betWeen Waco and WBl strains (X2 test, df 0 1, P>0.05). 
The present method provides the ability to arti?cially 
infect A. aegypli With WAlbB Where A. aegypli is a major 
disease vector, and thus represents an important step toWard 
proposed population replacement strategies. The observed 
high CI rates, high maternal inheritance, and ability of WAlbB 
to invade an uninfected laboratory population to infection 
?xation represent desired characteristics for population 
replacement strategies. 
Example 3 
The Transfer of Wolbachia from Drosophila 
Stimulants into the Invasive Pest and Disease Vector: 
Aedes albopiclus (Asian Tiger Mosquito) 
The folloWing example demonstrates the maintenance of 
infection in a transfected mosquito strain (HTR), displaying 
an ability to induce cytoplasmic incompatibility and maternal 
transmission rates similar to that observed in D stimulants. 
The HTR strain is bidirectionally incompatible With naturally 
infected Ae. albopiclus, alloWing for the use of HTR to sup 
press ?eld populations. An initial laboratory test of the latter 
suppression strategy, demonstrates that HTR male releases 
into naturally infected Ae. albopiclus populations results in 
reduced egg hatch. 
This example generates an arti?cial Wolbachia infection 
useful for Ae. albopiclus suppression. Ae. albopiclus Was 
selected due to its importance as a pest and disease vector, the 
ability of Ae. albopiclus to naturally support Wolbachia infec 
tion (unlike Ae. aegypli and Anopheles sop., Which are not 
naturally infected), and the previously developed microinj ec 
tion technique as taught in Xi and Dobson 2005. 
The results demonstrate that the WRi infection has been 
successfully transferred from Drosophili a into Ae. albopiclus 
and is stably maintained in the transfected line (HTR). The 
HTR line displays a unique CI pattern and is bidirectionally 
incompatible With both natural infections and the previously 
generated arti?cial infection as taught by Xi and Dobson 
2005. Initial suppression trails shoW that releases of HTR 
males into laboratory cages of superinfected populations 
result in reduced egg hatch. 
Individuals With the Ae. albopiclus Houston (Hou) strain 
are naturally superinfected With both the WAlbB and WAlbA 
Wolbachia types in accordance With Sinkins, S. P., Brig, H. R. 
& O’Neil, S. L. (1995) “Wolbachia superinfections and the 
expression of cytoplasmic incompatibility” Proc R Soc Lund 
[Boil] 261, 325-330, herein incorporated by reference. The 
aposymbiotic HT1 strain Was generated by tetracycline treat 
ment of the Hou strain. The Koh Samui strain (Koh) is natu 
rally single infected With the WAlbA Wolbachia type. The 
HOB strain is single infected With WAlbB and Was arti?cially 
generated via microinjection of HT1 With Hou cytoplasm in 
accordance With Xi and Dobson 2005. D. stimulants River 
side (DSL) are naturally infected With the WRi infection. 
Mosquito and Drosophilia strains Were maintained folloWing 
standard procedures as described previously in Roberts, D. B. 
(1998) Drosophila: a practical approach (GIRL Press at 
Oxford University Press, Oxford) and Dobson, S. L., Marsh 
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land, E. J. & Rattanadechakul W. (2001) “ Wolbachia-induced 
cytoplasmic incompatibility in singe- and superinfected 
Aedes albopiclus.” J. Med. Entomol. 38, 382-387, (hereinaf 
ter Dobson et al. 2001), both herein incorporated by refer 
ence. 
Embryo injection Was based upon techniques successfully 
used for mosquito and Drosophi li a transfection in accordance 
With Xi, Z., & Dobson, SAL., 2005, “Characterization of 
Wolbachia transfection ef?ciency by using microinjection of 
embryonic cytoplasm and embryo homogenate” Appl Envi 
ron MicrobioL, 71, 3199-3204, (hereinafter Xi et al. 2005) 
and Xi and Dobson 2005. Microinjection needles Were pre 
pared from quartZ microcapilaries (#QF100-70-75; Sutter 
Instrument Co., Novato, Calif.) using a P2000 micropipette 
puller (Sutter Instrument Co., Novata, Calif.). 
DSR embryos Were used as the donor of WRi infected 
cytoplasm. DSR embryos Were collected 230 min post ovi 
position using apple juice agar plates With yeast paste. 
Embryos Were dechorionated in 50% bleach for 2 minutes, 
rinsed, aligned on agar plate and transferred onto a glass slide 
With double stick tape, and covered With Water saturated 
halocarbon 700 oil (Sigma-Aldrich Co.). Donor DSR 
embryos Were not desiccated. 
HT1 embryos (recipient embryos) Were aligned on Wet 
?lter paper, transferred onto a cover slip With double sided 
tape (Scotch 665; St. Paul, Minn.), brie?y desiccated, and 
covered With Water saturated halocarbon 700 oil. Embryos 
Were injected 290 minutes post oviposition. 
Cytoplasm Was WithdraWn from the posterior of donor 
DSR embryos and injected into the posterior of recipient HT1 
embryos using an IM300 microinjector (N arishige Scienti?c; 
Tokyo, Japan) similar to prior descriptions of Xi et al. 2005 
and Xi and Dobson 2005. 
FolloWing injection, HT1 embryos Were incubated at 80% 
relative humidity and 270 C. for approximately 40 minutes. 
Subsequently, the embryos Were removed from the oil and 
transferred onto Wet ?lter paper, Where they Were alloWed to 
develop for ?ve days. The eggs Were then submerged in 
deoxygenated Water to hatch. Resulting larvae (GO) Were 
reared using standard conditions as described above. 
Enclosing GO females Were isolated as pupae to assure 
virginity and Were subsequently mated With HT1 males. Fol 
loWing blood feeding and oviposition, GO females Were 
assayed for Wolbachia infection via PCR (described beloW). 
GO males Were assayed for Wolbachia infection approxi 
mately tWo days post eclosion. GO females testing negative for 
Wolbachia infection Were discarded along With their progeny. 
One WRi infected line Was selected for subsequent experi 
ments and designated as the “HTR” strain: Houston strain, 
Tetracycline treated, With WRi infection. HTR individuals 
Were sibling mated in the G1 and G2. Beginning in G3, 50 
virgin HTR females Were out crossed With 50 HT1 males in 
every generation. 
Crosses Were conducted to characterize the pattern of CI 
and egg hatch rates resulting from crosses betWeen HTR 
individuals and individuals With differing Wolbachia infec 
tion types. In all crosses, ten virgin females Were mated With 
ten males. All individuals Were <5 days old When crossed. 
Subsequently, females Were blood fed and provided With 
oviposition cups. 
For PCR assays, DNA Was extracted from adult ovaries or 
testis via homogeniZation in 100 pl STE With 0.4 mg/ml 
proteinase K as previously described in O’Neill, S. L., Gior 
dano, R., Colbert, A. M., Karr, T. L., & Robertson, H. M., 
1992, 16S “rRNA phylogenetic analysis of the bacterial 
endosymbionts associated With cytoplasmic incompatibility 
in insects”PNAS 89, 2699-2702, (hereinafter O’Neill), herein 
incorporated by reference. Presence of Wolbachia Was 
detected using general Wolbachia primers (81F, 691R) as 
taught in Zhou, W., Rousset, E, & O’Neill, S. L., 1998, 
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“Phylogeny and PCR based classi?cation of Wolbachia 
strains using Wsp gene sequences” Proc R Soc Lond Biol. 
265, 509-515, (hereinafter Zhou et al.). Wolbachia infection 
type Was determined using primers speci?c for the WAlbA 
(328F, 691 R), WAlbB (183F, 691R) and WRi (169F, 569R) 
infections in accordance With Zhou et al. and Kang, L., Ma, 
X., Cai, L., Liao, S., Sun, L., Zhu, H., Chen, X., Shen, D., 
Zhao, S., & Li, C., 2003, “Superinfection of Laodelphax 
slrialellus With Wolbachia from Drosophila simulans” 
Heredity 90, 71-76, herein incorporated by reference. As 
additional con?rmation of infection type, primers speci?c for 
a prophage sequence (phgWOf, phgWOr) Were used. The 
latter primers result in a PCR ampli?cation product With WRi 
but not With WAlbA or WAlbB infections in Hou. For mos 
quitoes failing to amplify the above primers (e.g. HT1), tem 
plate quality Was con?rmed using 12S mitochondrial primers 
as previously disclosed in O’Neill. For FISH, oocytes Were 
dissected from females four days after blood feeding and 
Were ?xed for 15 min in freshly prepared 4% formaldehyde in 
PBS and then FISH stained as described previously in Xi and 
Dobson 2005. For the maternal transmission assay, tWenty 
HTR G5 females and eleven HTR G6 females Were randomly 
selected and PCR assayed. Progeny (G7) from one infected 
HTR G6 female Were reared to adult and PCR tested. In each 
generation, the maternal transmission ef?ciency Was esti 
mated using the percentage of PCR positive individuals 
among those tested. 
All mosquitoes used in suppression cage tests Were iso 
lated as pupae to assure virginity. Fifty Hou females and ten 
Hou males Were present in all of the cages. The number of 
HTR males (G5) Was varied betWeen cages. Male Hou:HTR 
ratios Were: 10:500, 10:100, 10:20, and 10:0. All males Were 
<1 Week post eclosion. One day after adding males to cages, 
?fty Hou females (<1 Week past eclosion) Were added to each 
cage. Prior to adding females, cages Were examined to assure 
that minimal male mortality had occurred. Mating Was 
observed immediately upon addition of females to cages. 
FolloWing blood feeding, females Were alloWed to oviposit 
for one Week. Egg hatch rates Were determined as described 
above. 
Cytoplasm from WRi infected D. simulans Riverside 
embryos Was microinjected into aposymbiotic HT1 Ae. 
albopiclus embryos. A total of 695 HT1 eggs Were injected in 
three experiments, resulting in 15 GO females that survived to 
adult summarized in Table 3. PCR assays Were conducted to 
diagnose Wolbachia infection in GO adults. As shoWn in Table 
3, Wolbachia infection Was detected in 33% of surviving GO 
females and 40% of surviving GO males. 
TABLE 3 
Survival of microinjected Ae. albopictus embryos, and the resulting 
Wolbachia infection status in the GO individuals surviving to adult. 
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mated, blood fed, isolated and alloWed to oviposit. FolloWing 
oviposition, the G1 females Were PCR assayed for Wolbachia 
infection similar to GO females. Each of the three G1 females 
tested positive for Wolbachia infection. One of the latter 
isofemale lines Was randomly selected for subsequent experi 
ments and designated as the HTR strain. Subsequently, PCR 
assays of HTR individuals have consistently detected Wolba 
chia infection through G9. 
As an initial characteriZation of the maternal transmission 
rate, HTR females Were examined at G5, G6 and G7. At G5, 20 
females Were randomly selected and PCR assayed for Wol 
bachia infection. Wolbachia ampli?cation products Were 
observed in 90% of the females.A repeat of this experiment at 
G6 observed 11/11 (100%) females to be infected. The prog 
eny (G7) from one of the infected G6 females Were reared to 
adult and PCR tested. In the latter test, PCR ampli?cation 
products Were observed in 18/20 (90%) of the assayed G7 
females. 
Fluorescent in situ hybridization (FISH) Was used to exam 
ine the distribution of Wolbachia in transfected HTR oocytes. 
Wolbachia localiZation in HTR oocytes Was observed to dif 
fer from that observed in naturally superinfected Hou oocytes 
as shoWn in FIG. 7. Wolbachia Was observed to be concen 
trated toWards the center of HTR oocytes. In contract, the 
anterior and posterior is the focus of infection in naturally 
infected Hou oocytes and the transfected HTB strains. 
To determine the type of Wolbachia infection present in 
HTR, diagnostic PCR primers Were used as shoWn in FIG. 8. 
Consistent With expectations for host insects infected With the 
WRi infection only, PCR assays of the HTR and DSR indi 
viduals result in ampli?cation products of the expected siZe 
using the 169F/569R primer set, but not With the 328F/691R 
primer sets. The 169F/ 569R primer set did not amplify any of 
the otherAe. albopiclus strains.As an additional con?rmation 
of Wolbachia type, DNA from each of the Ae. albopiclus 
strains and DSR ?ies Was ampli?ed using the phgWOf/phg 
WOr primer set. The latter ampli?cation Was similar to the 
169F/569R primer set in that ampli?cation products Were 
only obtained from HTR and DSR. The Koh and HTB strains 
amplify With the 328F/691 R or 183F/691R primer sets. The 
HT1 strain does not amplify With the Wolbachia-speci?c 
primers. 
Given that the WRi causes CI in its natural D. simulans ho st, 
crosses betWeen HTR and HT1 Were conducted to determine 
the CI pattern relative to the other Ae. albopiclus. Additional 
crosses Were conducted to determine the CI pattern relative to 
other Ae. albopiclus infections (i.e. the WAlbA single infec 
tion, the WAlbB single infection, and the superinfection). As 
shoWn in Table 4, crosses of HTR individuals With the other 
infection types resulted in a unique pattern of Cl. Speci?cally, 
a typical pattern of unidirectional CI Was observed in crosses 
in crosses betWeen HTR With uninfected HT1 individuals. 
Bidirectional CI Was observed in crosses of HTR With single 
infected (Koh, HTB) and superinfected (Hou) individuals. 
TABLE 4 
Percent Survival GO Infection 
Hatch Pupation Eclosion Sex ratio Status 
(Larvae/ (Pupae/ (Adult/ (Female/ (Infected/total) 
Experiment eggs) larvae) pupae) male) 9 d 
1 3.4% 75.0% 83.3% 100.0% 40.0% (0/0) 
(8/233) (6/8) (5/6) (5/5) (2/5) 
2 1.9% 50.0% 100.0% 66.7% 0% 0% 
(6/316) (3/6) (3/3) (2/3) (0/2) (0/1) 
3 15.8% 78.3% 66.7% 66.7% 37.5% 50% 
(23/146) (18/23) (12/18) (8/12) (3/8) (2/4) 
Of the ?ve PCR positive GO females, only one female 
produced hatching eggs. The remaining GO females either 
failed to oviposit or their eggs failed to hatch. Three daughter 
(G1) resulting from the PCR positive GO female Were sib 
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Egg hatch resulting from crosses of the transfected HTR line (G1) 
Expected CI Infection Type Percent Egg Eggs 
Type Cross* Female Male Hatch” scored 
Bidirectional Koh x HTR WAlbA WRi 5.9 r 4.8% 2119 
CI HTR x Koh WRi WAlbA 2.8 r 1.5% 2040 
HTB x HTR WAlbB WRi 9.9 r 5.4% 1434 
HTR x HTB WRi WAlbB 0.3 r 0.5% 2152 
Hou x HTR WAlbA, WRi 14.2 r 6.6% 2972 
WAlbB 
HTR x Hou WRi WAlbA, 0.4 r 0.4% 3216 
WAlbB 


